Inactive Instrument

Callitas Health Inc. Stock price Canadian Securities Exchange

Equities

LILY

CA13125C1068

Biotechnology & Medical Research

Sales 2018 0.75 1.02 Sales 2019 0.71 0.96 Capitalization 3.53M 4.77M
Net income 2018 -5M -6.77M Net income 2019 -1M -1.35M EV / Sales 2018 4,852,616 x
Net Debt 2018 319K 432K Net Debt 2019 848K 1.15M EV / Sales 2019 6,168,166 x
P/E ratio 2018
-0.6 x
P/E ratio 2019
-1.97 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 72.04%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 18-01-02
Director of Finance/CFO 42 -
Director/Board Member 47 -
Members of the board TitleAgeSince
Director/Board Member 69 14-11-30
Director/Board Member - -
Director/Board Member 47 -
More insiders
Callitas Health Inc is a Canada-based company that is primarily engaged in integrated clinical-stage pharmaceutical development and over-the-counter (OTC) consumer goods marketing. The Company provides biomedical technologies and products. The Company offers drug treatments for obesity, infertility, intimacy issues, weight management, female sexual dysfunction solutions and women wellness.
More about the company
  1. Stock
  2. Equities
  3. Stock Callitas Health Inc.
  4. Stock Callitas Health Inc. - Canadian Securities Exchange